The dapivirine vaginal ring (DVR) and oral pre-exposure prophylaxis (PrEP) was safe and effective at preventing HIV in pregnant cisgender women, who are three times more likely to acquire HIV through sexual intercourse than similarly aged people who are not pregnant, according to Felix Mhlanga, Bsc HPT, MBChB, MMed, an obstetrician-gynocologist at the University of Zimbabwe Clinical Trials Centre.
This study, presented at CROI 2024, in Denver, marks a significant advancement